Nothing Special   »   [go: up one dir, main page]

Cai et al., 1994 - Google Patents

Resting and activated T cells display different requirements for CD8 molecules.

Cai et al., 1994

View PDF
Document ID
17681393556268269844
Author
Cai Z
Sprent J
Publication year
Publication venue
The Journal of experimental medicine

External Links

Snippet

Clonotype-positive (1B2+) T cells from 2C T cell receptor (TCR) transgenic mice were used to define the role of CD8 molecules in the induction phase vs. the effector phase of the primary response to class I alloantigens. Three main findings are reported. First, in the …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system

Similar Documents

Publication Publication Date Title
Cai et al. Resting and activated T cells display different requirements for CD8 molecules.
Racioppi et al. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
Chikuma CTLA-4, an essential immune-checkpoint for T-cell activation
Schild et al. The nature of major histocompatibility complex recognition by γδ T cells
Workman et al. The CD4‐related molecule, LAG‐3 (CD223), regulates the expansion of activated T cells
Lucas et al. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response.
Boussiotis et al. Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation.
Galvin et al. Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation.
Holler et al. CD8− T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation
Baecher-Allan et al. CD4+ CD25high regulatory cells in human peripheral blood
Roy et al. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.
Sperling et al. CD43 is a murine T cell costimulatory receptor that functions independently of CD28.
Evans et al. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40
Combadiere et al. Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis.
KR20210019993A (en) Τ Cell receptor and engineered cells expressing it
Geppert et al. Activation of human T cell clones and Jurkat cells by cross-linking class I MHC molecules.
Wade et al. Altered IA protein-mediated transmembrane signaling in B cells that express truncated I-Ak protein.
Ohnuma et al. Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs
US20060063256A1 (en) Human regulatory T cells and uses thereof
WO2002080963A1 (en) Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment
JP2002186486A (en) Ligand for cd28 receptor on b cell and method for regulating intercellular interaction using the ligand
KR20200085362A (en) Novel generation of antigen-specific tcrs
Mullins et al. Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines.
JP2022538148A (en) T cell receptor that recognizes R175H or Y220C mutations in p53
STONEHOUSE et al. Molecular characterization of U937‐dependent T‐cell co‐stimulation